FDA — authorised 11 December 1989
- Application: NDA050637
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: ZEFAZONE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Zefazone on 11 December 1989
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 11 December 1989; FDA has authorised it.
PHARMACIA AND UPJOHN holds the US marketing authorisation.